Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases with operations in the United States and Europe.

Recs

0
Player Avatar explainstuff (99.25) Submitted: 12/23/2011 4:52:32 PM : Underperform Start Price: $6.99 IDIX Score: -33.83

Pharmacycle... looking for a dip.

Featured Broker Partners


Advertisement